Park Ha Biological Technology Co. Ltd (BYAH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 10/31
(Values in U.S. thousands)
| 10-2025 | 04-2025 | 01-2025 | 12-2024 | 10-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -24,365 | -19,836 | 479 | 479 | 479 |
| Depreciation Amortization | 109 | 16 | 23 | 23 | 23 |
| Income taxes - deferred | N/A | -2 | N/A | N/A | N/A |
| Accounts receivable | N/A | 201 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | N/A | -7 | N/A | N/A | N/A |
| Other Working Capital | -92 | 121 | 254 | 254 | 254 |
| Other Operating Activity | 24,433 | 19,753 | 204 | 204 | 204 |
| Operating Cash Flow | $86 | $245 | $960 | $960 | $960 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -89 | -2 | -86 | -86 | -86 |
| Other Investing Activity | -484 | -3,260 | -422 | -422 | -422 |
| Investing Cash Flow | $-573 | $-3,262 | $-508 | $-508 | $-508 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 8 | N/A | N/A | N/A |
| Common Stock Issued | N/A | 4,278 | N/A | N/A | N/A |
| Other Financing Activity | 3,736 | -452 | -957 | -957 | -957 |
| Financing Cash Flow | $3,736 | $3,834 | $-957 | $-957 | $-957 |
| Exchange Rate Effect | -8 | -13 | 19 | 19 | 19 |
| Beginning Cash Position | 547 | 548 | 1,034 | 1,034 | 1,034 |
| End Cash Position | 3,788 | 1,351 | 547 | 547 | 547 |
| Net Cash Flow | $3,240 | $804 | $-486 | $-486 | $-486 |
| Free Cash Flow | |||||
| Operating Cash Flow | 86 | 245 | 960 | 960 | 960 |
| Capital Expenditure | N/A | -2 | N/A | N/A | N/A |
| Free Cash Flow | 86 | 243 | 960 | 960 | 960 |